JAMA Cardiol. 2026 Mar 4. doi: 10.1001/jamacardio.2026.0006. Online ahead of print.ABSTRACTIMPORTANCE: Familial hypercholesterolemia (FH) is a common genetic condition that causes hypercholesterolemia and increased risk for premature atherosclerotic cardiovascular disease (ASCVD). The prevalence, ma
JAMA Cardiol. 2026 Mar 4. doi: 10.1001/jamacardio.2026.0068. Online ahead of print.ABSTRACTIMPORTANCE: Mounting evidence suggests that renin-independent aldosteronism is common and often underrecognized. Yet, whether aldosteronism across this broader spectrum is associated with incident cardiovascul
Am J Physiol Heart Circ Physiol. 2026 Mar 4. doi: 10.1152/ajpheart.00739.2025. Online ahead of print.ABSTRACTThe technique of microneurography has advanced our understanding of the sympathetic nervous system's role in the neurovascular control of blood pressure in humans, yet critical knowledge gaps
ZnT1 is the main transporter mediating Zn²⁺ efflux from the cytoplasm to the extracellular space. Paradoxically, due to relatively low Zn^(2+) affinity of ZnT1, physiological levels of cytoplasmic free Zn^(2+) are seemingly insufficient to support ZnT1 function. However, physiological modulation of
No abstractPediatr Cardiol. 2026 Mar 4. doi: 10.1007/s00246-026-04198-z. Online ahead of print.NO ABSTRACTPMID:41779175 | DOI:10.1007/s00246-026-04198-z
Clin Res Cardiol. 2026 Mar 4. doi: 10.1007/s00392-026-02874-x. Online ahead of print.ABSTRACTOBJECTIVES: To investigate the long-term outcomes and risk factors for morbidity and mortality in patients with Ebstein's anomaly, including the effects of type and timing of valve surgery.METHODS: For this
J Physiol. 2026 Mar 4. doi: 10.1113/JP289780. Online ahead of print.ABSTRACTExogenous glucocorticoid (GC) therapy, whether physiological replacement in adrenal insufficiency or pharmacological treatment of inflammatory diseases, confers significant cardiometabolic risks, including obesity and insuli
Saudi Pharm J. 2026 Mar 4;34(2):11. doi: 10.1007/s44446-026-00070-6.ABSTRACTDiabetes mellitus is a metabolic disease manifested by hyperglycemia, leading to critical health challenges in the kidneys, eyes, nerves, and cardiovascular system. Aloe vera (Aloe barbadensis miller), a traditionally used h
Bull Math Biol. 2026 Mar 4;88(4):52. doi: 10.1007/s11538-026-01618-2.ABSTRACTSpatial transcriptomics studies are becoming increasingly large and commonplace, necessitating simultaneous analysis of a large number of spatially resolved variables. Correspondingly, a diverse range of methodologies have
Biochem Genet. 2026 Mar 4. doi: 10.1007/s10528-026-11343-z. Online ahead of print.ABSTRACTThe emergence and progression of a range of cardiovascular and cerebrovascular conditions are linked to endothelial dysfunction. Nevertheless, the specific pathways leading to damage in vascular endothelium rem
Cardiol Rev. 2026 Mar 4. doi: 10.1097/CRD.0000000000001228. Online ahead of print.ABSTRACTAn elevated lipoprotein (a) concentration has been established as an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). There is a high prevalence of elevated lipoprotein (a) in the gen
Inn Med (Heidelb). 2026 Mar 4. doi: 10.1007/s00108-026-02067-8. Online ahead of print.ABSTRACTCardiovascular diseases are the most frequent cause of death for both women and men in Germany. A proportion of 50-70% of the morbidity and mortality of these diseases would be avoidable by the timely recog
No abstractJ Am Coll Cardiol. 2026 Feb 25:S0735-1097(26)00230-5. doi: 10.1016/j.jacc.2026.01.053. Online ahead of print.NO ABSTRACTPMID:41778960 | DOI:10.1016/j.jacc.2026.01.053
J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00207-X. doi: 10.1016/j.jacc.2026.01.041. Online ahead of print.ABSTRACTBACKGROUND: Prevalence and severity of coronary atherosclerosis in liver transplant (LTx) recipients remain poorly characterized because prior work has relied on clinically indicated i
No abstractJ Am Coll Cardiol. 2026 Feb 19:S0735-1097(26)00136-1. doi: 10.1016/j.jacc.2026.01.026. Online ahead of print.NO ABSTRACTPMID:41778953 | DOI:10.1016/j.jacc.2026.01.026
J Am Coll Cardiol. 2026 Feb 11:S0735-1097(25)10555-X. doi: 10.1016/j.jacc.2025.11.054. Online ahead of print.ABSTRACTDurable left ventricular assist devices (dLVAD) remain a lifesaving therapy in patients with stage D heart failure that is refractory to conventional medical therapies. Owing to impro
J Am Coll Cardiol. 2026 Feb 2:S0735-1097(25)10408-7. doi: 10.1016/j.jacc.2025.12.004. Online ahead of print.ABSTRACTBACKGROUND: Mitral annular calcification (MAC)-related mitral stenosis is associated with increased mortality, but robust long-term outcomes remain unclear.OBJECTIVES: The aim of this
J Am Coll Cardiol. 2026 Feb 25:S0735-1097(26)00233-0. doi: 10.1016/j.jacc.2025.12.090. Online ahead of print.ABSTRACTBACKGROUND: Conventional antiarrhythmic drugs that target cardiac ion channels carry proarrhythmic risks, highlighting the need for alternative therapeutic approaches. Cardiac nicotin
J Am Coll Cardiol. 2026 Feb 25:S0735-1097(26)00070-7. doi: 10.1016/j.jacc.2026.01.010. Online ahead of print.ABSTRACTBACKGROUND: The routine implementation of heart teams for patients with complex coronary artery disease (CAD) is challenging due to the insufficient multidisciplinary specialist resou
J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00147-6. doi: 10.1016/j.jacc.2026.01.035. Online ahead of print.ABSTRACTBACKGROUND: Data regarding long-term outcomes of intravascular imaging-guided percutaneous coronary intervention (PCI) for complex coronary artery lesions, compared with angiography-gu
Diabetes Care. 2026 Mar 4:dc253063. doi: 10.2337/dc25-3063. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the comparative effectiveness of dulaglutide or semaglutide versus tirzepatide on cardiovascular outcomes in adults with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (
Microbiol Spectr. 2026 Mar 4:e0097125. doi: 10.1128/spectrum.00971-25. Online ahead of print.ABSTRACTDyslipidemia, characterized by abnormal blood lipid levels, constitutes a significant risk factor for cardiovascular disease. Emerging evidence indicates that the gut microbiota influences lipid meta
No abstractJACC Asia. 2026 Mar;6(3):394-396. doi: 10.1016/j.jacasi.2025.12.012.NO ABSTRACTPMID:41778704 | DOI:10.1016/j.jacasi.2025.12.012
No abstractJACC Asia. 2026 Mar;6(3):390-393. doi: 10.1016/j.jacasi.2025.12.013.NO ABSTRACTPMID:41778703 | DOI:10.1016/j.jacasi.2025.12.013
